Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 394 of 1,261
  1. US 10793636

    Anti-CD73 antibodies

    Corvus Pharmaceuticals, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  2. US 10791731

    Methods for preparing frozen plasma material for rapid thawing in an emergency situation

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  3. US 10792481

    Implantable drug delivery device

    Nano Precision Medical, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  4. US 10792251

    Liposomal particles, methods of making same and uses thereof

    Northwestern University · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  5. US 10792274

    Dehydroacetic acid (DHAA) and derivative for uses in treating cancer

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  6. US 10792276

    Urolithins as immune response enhancers

    Amazentis SA · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  7. US 10792282

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  8. US 10792353

    Virus like particle purification

    Takeda Vaccines, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  9. US 10792312

    Barrier layer

    ATRIUM MEDICAL CORPORATION · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  10. US 10792363

    Anhydrous sodium thiosulfate and formulations thereof

    Fennec Pharmaceuticals, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  11. US 10793482

    Compounds and compositions for delivery of nutrients and micronutrients to plants

    Spero Energy, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  12. US 10792368

    Bicyclic peptide ligands specific for MT1-MMP

    BicycleRD Limited · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  13. US 10792370

    Antibody-drug conjugate

    SHANGHAI MIRACOGEN INC. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  14. US 10793547

    Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  15. US 10793595

    Toll-like receptor 2 ligands and methods of making and using thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  16. US 10793564

    Amino acid compounds and methods of use

    Pliant Therapeutics, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  17. US 10793563

    GCN2 inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  18. US 10793624

    Human antibodies to Bet v 1 and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  19. US 10793846

    Compositions and methods for treating celiac sprue disease

    The Regents of the University of California · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  20. US 10793884

    Methods and materials for making simvastatin and related compounds

    The Regents of the University of California · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  21. US 10793862

    Compositions and methods for modulating growth hormone receptor expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  22. US 10793865

    Transferrable mechanism of generating inducible, BAR domain protein-mediated bacterial outer membrane extensions

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  23. US 10793878

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  24. CA 3133787

    GELS HOMOGENES INJECTABLES COMPRENANT DE MULTIPLES FORMES D'ACIDE HYALURONIQUE ET LEURS PROCEDES DE FABRICATION

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Oct 1, 2020 · Expires Sep 26, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.